Murat SUCU, Gökhan ALTUNBAŞ, Mesut OZKAYA, Zeynel Abidin SAYİNER

The association of epicardial fat thickness and disease severity among Fabry patients

Aim: Patients with Fabry disease frequently die due to cardiovascular causes. There are numerous findings of cardiovascularinvolvement in patients with Fabry disease. Epicardial fat thickness is a surrogate for various cardiovascular diseases. In this study,we evaluated epicardial fat thickness and parameters of diastolic dysfunction among Fabry patients as a possible indicator ofdisease severity.Materials and Methods: We enrolled 14 patients with Fabry disease who receive enzyme replacement therapy. Detailedechocardiographic examination was performed including diastolic functions and measurement of epicardial fat thickness. Diseaseseverity was assessed using DS3 scoring system. Based on DS3 scores, patients are grouped into mild (

PDF

___

1. Germain DP. Fabry disease. Orphanet J Rare Dis 2010;5:30
2. Baig S, Edward NC, Kotecha D, Liu B, Nordin S, Kozor R, et al. Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice. Europace 2017 doi: 10.1093/europace/eux261.
3. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol2015;11:363-71
4. Rozenfeld P, Feriozzi S. Contribution of inflammatory pathways to Fabry disease pathogenesis. Mol Genet Metab. 2017;122:19-27
5. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am SocEchocardiogr 2009;22:1311-9
6. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 2016;29:277-314
7. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 2015;28:1-39.
8. Giannini EH, Mehta AB, Hilz MJ, Beck M, Bichet DG, Brady RO, et al. A validated disease severity scoring system for Fabry disease. Mol Genet Metab 2010;99:283-90
9. Levey AS, Greene T, Kusek JW, Beck GL; MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000 Sep; 11:155A
10. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:304-10.
11. Iacobellis G, Willens HJ, Barbaro G, et al. Threshold values for high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 2008;16:887-92.
12. Constricte A, Petramala L, Scoccia G, et al. Epicardial fat thickness in patients with autosomal dominant polycystic kidney disease. Cardiorenal Med 2018;8:199-207.
13. Iacobeliis G, Barbarini G, Letizia C, et al. Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring) 2014;22:332-6.
14. Gürdal A, Keskin K, Orken DN, et al. Evaluation of epicardial fat thickness in young patients with embolic stroke of undetermined source. Neurologist 2018;23:113-117.
15. Ahn SG, Lim HS, Joe DY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008;94:e7.
16. Eroglu S, Sade LE, Yildirir A, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009;19:211-7.
17. Park JS, Lee YH, Seo KW, et al. Echocardiographic epicardial fat thickness is a predictor for target vessel revascularization in patients with ST-elevation myocardial infarction. Lipids Health Dis 2016;15:194.
18. Waldek S, Patel MR, Banikazemi M, et al. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med 2009;11:790-6.
19. Patel MR, Cecchi F, Cizmarik M, et al. Cardiovascular events in patients with fabry disease natural history data from the fabry registry. J Am Coll Cardiol 2011;57:1093-9.
20. Dabbah S, Komarov H, Marmor A, et al. Epicardial fat, rather than pericardial fat, is independently associated with diastolic filling in subjects without apparent heart disease. Nutr Metab Cardiovasc Dis 2014;24:877-82.
21. Hachiya K, Fukuta H, Wakami K, et al. Relation of epicardial fat to central aortic pressure and left ventricular diastolic function in patients with known or suspected coronary artery disease. Int J Cardiovasc Imaging 2014;30:1393-8.